London, July 29, 2010 (ots/PRNewswire) - HCL Technologies Ltd. (HCL), a leading global IT services provider, today announced results for the annual and quarter ended June 30 2010. For the full year, HCL's global revenues increased by 24.1% to $2.7bn. During the quarter, HCL posted strong growth with revenues ...
Monheim, Germany, July 28, 2010 (ots/PRNewswire) - Fascinating studies giving new insights into the spread of leishmaniosis in the UK and France, the appearance of new CVBDs in Germany, the state of heartworm infection in Korea and the neurological impact on humans of long-term bartonella infection from the USA are among the papers now available for download ...
Geneva (ots) - - - Union Bancaire Privée (UBP) has announced net earnings of CHF 103.3 million (USD 95.6 million) at the end of the first half of 2010, in line with expectations. - UBP attracted CHF 3.4 billion (USD 3.1 billion) in capital inflows in the first half of 2010 and has seen its total ...
Vancouver, July 22, 2010 (ots/PRNewswire) - Bayer Animal Health today revealed their new commitment to the livestock community at the 21st International Pig Veterinary Society (IPVS) Congress in Vancouver, Canada. "This year's congress highlights the complex and rapidly changing world pig production operates in and the need for constant innovation from everyone ...
Wokingham, England, July 22, 2010 (ots/PRNewswire) - Kowa are delighted to announce that following the completion of the decentralized regulatory procedure, that their statin, pitavastatin has achieved a positive outcome from the UK Regulatory Authority (MHRA) acting as the Reference Member State for 16 EU countries. Pitavastatin is indicated for the reduction ...
Basel, Switzerland, July 21, 2010 (ots/PRNewswire) - New data show that Avastin(R) (bevacizumab) based therapy provides a median overall survival (OS) of 14.6 months with a range of chemotherapies routinely used in clinical practice and in a broad population of patients with advanced non-small cell lung cancer ...
New York, July 20, 2010 (ots/PRNewswire) - Emailvision, the global market and technology leader in software as a service (SaaS) for email marketing, announces its 2010 first-half revenues. EUR millions 2010 2009 Increase Revenues - Q1 9.0 6.2 + 45% Revenues - Q2 10.3 7.0 + 47% Revenues - H1 19.3 13.2 + 46% Backlog as at 30 ...
Genf (ots) - WISeKey was invited last Tuesday by the Mayoress of Valencia, Rita Barberá, to meet with several political and business personalities of Valencia: Bruno Broseta, Regional Secretary for Industry, Commerce and Innovation for the Government of Valencia; Francisco Pons, President of AVE (Association of Valencian Entrepreneurs); Diego Lorente, Director ...
Montreal, July 15, 2010 (ots/PRNewswire) - To view this Social Media Release, please enter the following address in your web browser: http://smr.newswire.ca/en/kitco/kitco-metals-econference-attracts-ind ustry-heavyweights (Due to the length of the above URL, it may be necessary to copy and paste the hyperlink into your Internet browser's URL address field. ...
Irvine, California, and Amsterdam, July 15, 2010 (ots/PRNewswire) - Agendia, a world leader in molecular cancer diagnostics, announced today that company CEO Dr. Bernhard Sixt will provide testimony at a public meeting on July 20 in Washington D.C. on the federal regulation of laboratory developed tests (LDTs). Jointly organized by the Food and Drug Administration ...
Takeda Pharmaceutical Company Limited
London, July 15, 2010 (ots/PRNewswire) - The U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular (CV) safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ...
Dartmouth, Canada, July 12, 2010 (ots/PRNewswire) - Ocean Nutrition Canada (ONC) supplier of the most trusted source of Omega-3, EPA/DHA, food and dietary supplement ingredients, announces today the acquisition of the exclusive global marketing and distribution rights to GAT Food Essentials (GAT) ...
Paris, July 12, 2010 (ots/PRNewswire) - Valeo is taking part in the eSafety Challenge 2010 in Millbrook (UK) on July 13, 2010. On this occasion, the Group is presenting a selection of its latest visibility and driving assistance technologies, including advanced lighting and detection systems. In the area of lighting, the new Valeo camera-based ...
Tokyo, July 12, 2010 (ots/PRNewswire) - Daiichi Sankyo Company, Limited announced that its investigational once-daily oral, direct factor Xa inhibitor, edoxaban, was shown to be superior to enoxaparin in preventing venous thromboembolic (VTE) events in patients following total knee replacement (TKR), a type of ...
Institute for Brain and Spinal Cord Disorders (ICM)
Paris, July 8, 2010 (ots/PRNewswire) - Professor Gerard Saillant, President of the Institute for Brain and Spinal Cord Disorders (ICM), announced today an unprecedented donation of EUR8,000,000 from Mrs. Lily Safra. It is the largest single donation made by a private individual to the ICM. Professor Saillant ...
Paris, July 8, 2010 (ots/PRNewswire) - On the occasion of the Haute Couture, Chaumet is putting Tiaras and hair ornaments on the front line for the very first time, at 12, Place Vendome. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/chaumet/44181/ Jewels to be worn on the head that catch the light and embellish the eyes, "Josephine" tiaras, naturalistic headbands, ...
Ottawa, July 8, 2010 (ots/PRNewswire) - The United Nations General Assembly is considering an historic draft resolution recognizing the human right to "safe and clean drinking water and sanitation" initiated by the Bolivian government. Other member states have been consulted on the resolution and the final text is expected to be presented to the President of the General Assembly, for tabling by the end of July. In ...
Dartmouth, Canada, July 6, 2010 (ots/PRNewswire) - Ocean Nutrition Canada Limited - Long time Ocean Nutrition Canada Ltd. (ONC) President and CEO, Robert Orr, will make way for a new CEO to lead the company's next growth phase, with particular focus on international expansion efforts and the food sector. Martin Jamieson, a 30 year international food industry veteran, has been appointed as the new President and ...
Toronto, July 6, 2010 (ots/PRNewswire) - BioHub Inc., announced today the launch of BioHub-Online.org, a first-of- its-kind online platform to facilitate global networking and collaboration among research scientists. Antibodies are biomedical research reagents used for hundreds of thousands of experiments globally. The global market for research antibodies exceeds $2 billion, yet independent studies show that ...
Lugano (ots) - Helsinn's second-generation 5-HT3 RA Aloxi expands its presence in Asia through the Agreement signed with Mundipharma Helsinn Healthcare SA and Mundipharma International Corporation Ltd. announce the signature of a Distribution and Licensing Agreement for Helsinn's product palonosetron in Malesia, Philippines and Singapore. Aloxi® is a ...
New York, July 6, 2010 (ots/PRNewswire) - Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, ...
Monheim, Germany, July 6, 2010 (ots/PRNewswire) - The findings of a landmark Canine Vector Borne Disease (CVBD) prevention field study, published in Veterinary Parasitology today, showed the remarkable repelling efficacy of Advantix(R) in protecting dogs from ticks and sand flies and thereby reducing the risk of ...
Toronto, July 2, 2010 (ots/PRNewswire) - Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the Biosign products in Switzerland, Germany, France, and Austria, with an option to expand distribution throughout Europe. Under the terms of the agreement, DynamiCARE will pay an initial fee of CDN $2.5 million, with a ...
Castres, France, July 2, 2010 (ots/PRNewswire) - Olivier Bohuon will be replacing Jean-Pierre Garnier as Chief Executive Officer at Pierre Fabre Group starting September 1, 2010. Until now, Olivier Bohuon, 51, was Executive Vice-President of the Abbott Corporation and President of its pharmaceutical division. As such, he ran the group's entire pharmaceutical activities from Chicago ($22 billion in sales). In 2003, he was named the group's President for European ...
Copenhagen, June 30, 2010 (ots/PRNewswire) - The world's most-travelled hot dog stand is in South Africa during the FIFA World Cup 2010 to spread Danish culture and values and to raise money for education of South African bushmen children. The Danish hot dog stand, Hottie, has travelled around the world since 2003. Hottie generates its own electricity with pedal power and through the solar panels on the roof. More ...
Wokingham, England, June 28, 2010 (ots/PRNewswire) - Following an enthusiastic expansion programme into new markets, Kowa Company, Ltd. (President: Yoshihiro Miwa), headquartered in Nagoya, Japan, has granted Abbott, headquartered in Illinois, USA the exclusive license to distribute and market pitavastatin ...
Munich, June 28, 2010 (ots/PRNewswire) - Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Results from a 24-week Phase 3 clinical study demonstrated that the addition of the investigational drug dapagliflozin achieved reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients who were ...
Bristol-Myers Squibb and AstraZeneca
Orlando, Florida, June 26, 2010 (ots/PRNewswire) - Bristol-Myers Squibb Company and AstraZeneca today announced results from a 52-week Phase 3b study in adults with type 2 diabetes who had inadequate glycemic control on metformin therapy plus diet and exercise. This study found that the addition of ...